Safety of Neratinib (HKI-272) in Combination with Capecitabine in Patients with Solid Tumors: A Phase 1/2 Study.

Title
Safety of Neratinib (HKI-272) in Combination with Capecitabine in Patients with Solid Tumors: A Phase 1/2 Study.
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 69, Issue 24 Supplement, Pages 5108-5108
Publisher
American Association for Cancer Research (AACR)
Online
2010-12-31
DOI
10.1158/0008-5472.sabcs-09-5108

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search